| 1 |
35371997 | Multi-Faceted Effects of ST6Gal1 Expression on Precursor B-Lineage Acute Lymphoblastic Leukemia. | 2022 |
1 |
| 2 |
33242079 | Majority of alpha2,6-sialylated glycans in the adult mouse brain exist in O-glycans: SALSA-MS analysis for knockout mice of alpha2,6-sialyltransferase genes. | 2021 Jun 3 |
1 |
| 3 |
34206740 | Mesenchymal Stromal Cells Regulate Sialylations of N-Glycans, Affecting Cell Migration and Survival. | 2021 Jun 26 |
1 |
| 4 |
30730306 | Sialylation of MUC4β N-glycans by ST6GAL1 orchestrates human airway epithelial cell differentiation associated with type-2 inflammation. | 2019 Mar 7 |
1 |
| 5 |
30956133 | Transfer of Functional Cargo in Exomeres. | 2019 Apr 16 |
2 |
| 6 |
30959459 | A Golgi-associated redox switch regulates catalytic activation and cooperative functioning of ST6Gal-I with B4GalT-I. | 2019 Jun |
1 |
| 7 |
31395657 | Assembly of B4GALT1/ST6GAL1 heteromers in the Golgi membranes involves lateral interactions via highly charged surface domains. | 2019 Sep 27 |
2 |
| 8 |
31423157 | ST6GAL1: A key player in cancer. | 2019 Aug |
1 |
| 9 |
29475939 | The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling. | 2018 Apr 13 |
1 |
| 10 |
29569918 | Sialyltransferase-Based Chemoenzymatic Histology for the Detection of N- and O-Glycans. | 2018 Apr 18 |
2 |
| 11 |
28858492 | Cell-Surface Glyco-Engineering by Exogenous Enzymatic Transfer Using a Bifunctional CMP-Neu5Ac Derivative. | 2017 Sep 27 |
1 |
| 12 |
27018228 | Combining expression and process engineering for high-quality production of human sialyltransferase in Pichia pastoris. | 2016 Oct 10 |
1 |
| 13 |
27303031 | B-cell-independent sialylation of IgG. | 2016 Jun 28 |
1 |
| 14 |
27340870 | ST6Gal-I modulates docetaxel sensitivity in human hepatocarcinoma cells via the p38 MAPK/caspase pathway. | 2016 Aug 9 |
2 |
| 15 |
25344606 | β-Galactoside α2,6-sialyltranferase 1 promotes transforming growth factor-β-mediated epithelial-mesenchymal transition. | 2014 Dec 12 |
1 |
| 16 |
25556450 | ST6Gal-I predicts postoperative clinical outcome for patients with localized clear-cell renal cell carcinoma. | 2014 |
1 |
| 17 |
23358684 | ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines. | 2013 Apr 1 |
1 |
| 18 |
24129959 | Selective exo-enzymatic labeling of N-glycans on the surface of living cells by recombinant ST6Gal I. | 2013 Dec 2 |
2 |
| 19 |
24324693 | Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G. | 2013 |
1 |
| 20 |
21550977 | Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells. | 2011 Jul 1 |
1 |
| 21 |
19420742 | Importance of N-glycosylation on alpha5beta1 integrin for its biological functions. | 2009 May |
1 |
| 22 |
18080182 | Surface alpha 2-3- and alpha 2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis. | 2008 Apr |
2 |
| 23 |
18199532 | alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo. | 2008 Jan 15 |
1 |
| 24 |
21136920 | Aberrant expression of glycosylation in juvenile gastrointestinal stromal tumors. | 2008 Sep |
1 |
| 25 |
16897185 | Preferential reduction of the alpha-2-6-sialylation from cell surface N-glycans of human diploid fibroblastic cells by in vitro aging. | 2006 Jul |
2 |
| 26 |
11279145 | Exploring the acceptor substrate recognition of the human beta-galactoside alpha 2,6-sialyltransferase. | 2001 Jun 15 |
1 |
| 27 |
11406350 | Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro. | 2001 May 31 |
1 |